Skip to content

KETAMINE ABREACTION - TWO CASE REPORTS

Golechha Gr, Rao Av, Ruggu Rk

Indian Journal of Psychiatry October 1, 1985

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 2
Population Two patients undergoing narcoanalysis
Intervention Ketamine
Topics Esketamine Ketamine
Key findings The authors report an abreaction effect of ketamine in two cases and propose ketamine as an alternative to thiopentone for narcoanalysis, citing its intramuscular administration and safety profile.

Abstract

Ketamine is a rapid acting parentrally administered non barbiturate anaesthetic agent with minimum cardio respiratory depressant effect as compared to others (Paul et al 1982). It is in clinical use for more than ten years and used safely in aged and critically ill patients (Lorhan & Limppman 1971, Barson and Aren 1974). In sub-anaesthetic doses it has been safely used to produce obstetrical analgesia (Janeczko et al 1974). But the unpremedicated patients experience a dream like state. Since, it can be administered intramuscularly and is safer than thiopentone, we thought of using Ketamine as an alternative to thiopentone for narcoanalysis. We report in this paper our findings of abreaction effect of Ketamine on two cases.

Comparable studies

Other case reports and case series on ketamine, most cited first.

Study Year Design Participants
The destruction of the lower urinary tract by ketamine abuse: a new syndrome? Young recreational abusers of street-ketamine in Hong Kong referred to urology units 2008 Retrospective case series n = 59
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood. A patient with treatment-resistant depression and comorbid generalized anxiety... 2025 Case report n = 1
Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions Chronic and treatment-resistant eating disorder patients 1998 Case series n = 15
Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series Four depressed patients taking standard antidepressants 2009 Case series n = 4
A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression Patients with enduring eating disorders and treatment-resistant depression 2021 Case series n = 4

Explore topics